Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Supplemental Table 3 from Cytogenetic and Molecular Associations with Outcomes in Higher-Risk Myelodysplastic Syndromes Treated with Hypomethylating Agents plus Venetoclax

Alexandre Bazinet,Sai Prasad Desikan,Ziyi Li,Juan Jose Rodriguez-Sevilla,Sangeetha Venugopal,Samuel Urrutia,Guillermo Montalban-Bravo,Koji Sasaki,Kelly S. Chien,Danielle Hammond,Rashmi Kanagal-Shamanna,Irene Ganan-Gomez,Tapan M. Kadia,Gautam Borthakur,Courtney D. DiNardo,Naval G. Daver,Elias J. Jabbour,Farhad Ravandi,Hagop Kantarjian,Guillermo Garcia-Manero

crossref（2024）

Cited 0|Views17
No score
Abstract
Supplemental Table 3: Overall response rate and complete remission rate by venetoclax dose and schedule.
More
Translated text
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined